2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Carrie Horton, MS, CGC, discusses the importance of addressing the equity gap of genetic testing in cancer care.
Carrie Horton, MS, CGC, senior clinical research specialist, Ambry Genetics, discusses the importance of addressing the equity gap of genetic testing in cancer care.
Since studies have showed that underrepresented groups undergo genetic testing as a part of cancer care at lower rates vs other populations, it is important to look beyond traditional methods of referral for these underserved groups, Horton explains. Considering unconventional ways of gaining interest in genetic testing, such as through peer groups, may be beneficial to increase the rates of testing among underrepresented groups, Horton adds.
Laboratorians can also do their part in addressing these health disparities and taking steps to circumvent existing gaps in evidence, Horton continues. Functional evidence can be derived from new methods, and these can help deliver critical information regarding patient care while the gap in genetic testing is addressed, Horton concludes.